Management of Poisonous Snake Bites: Analysis of 29 Cases

Ayhan Akoz, Vahit Yildiz, Serhat Orun, Kenan Ahmet Turkdogan, Ali Duman

J Clin Exp Invest 2018;9(4):140-144.

https://doi.org/10.5799/jcei/3998

OPEN ACCESS

Download Full Text (PDF)

Abstract

Objectives: The objective of this retrospective study is to provide contribution for management of the poisonous snake bites by comparison results of this study with the literature data.
Patients and Methods: This study retrospectively analyzed the demographic and epidemiologic characteristics of 40 patients who presented due to snake bites. 29 patients were included in this study. Patients’ age, sex, month of admission, duration of follow-up in the emergency room, laboratory outcomes, the regions of snake bite, number of the bites, local and systemic symptoms, and treatment received were assessed. Patients aged under 18 years were excluded from the study. Also patients were excluded if the snakes were not seen after the patients were bitten or if they developed no local or systemic symptoms within four hours after the bite. In addition, patients in whom adequate data could not be obtained were also excluded from the study.
Results: Out of the 29 patients included in this study, 15 (51.7%) were females. When the patients were examined according to local and systemic findings; local symptoms were observed in 18 patients (62.1%) and systemic symptoms in 11 patients (37.9%). There was a positive correlation between elevated ALP and diffuse edema in the bite area and hypotension findings. When durations of hospitalization were analyzed, the mean duration of hospitalization was 2.3±1.5 days.
Conclusion: We believe that, symptomatic and supportive treatment could be sufficient in majority of the patients with snake bites in our region, and a low dose antiserum therapy would be reasonable when antiserum is needed.

Keywords

snake bite, antivenom, treatment

References

  • Mohapatra B, Warrell DA, Suraweera W, et al. Million Death Study Collaborators. Snakebite mortality in India: a nationally representative mortality survey. PloS Negl Trop Dsl. 2011;5:1018.
  • Baran İ, Başoğlu M. Türkiye Sürüngenleri, İzmir, Ege Üniversitesi Basımevi, 1998.
  • Okur MI, Yıldırım MA, Köse R. Venomous snakebites and its therapy in Turkey. Turkiye Klinikleri J Med Sci. 2001;21:528-32.
  • Kose R. The management of snake envenomation: evaluation of twenty-one snake bite cases. Turkish Journal of Trauma & Emergency Surgery 2007;13:307-12.
  • Araz M, Okan V, Demirci F. Yılan zehirlenmeleri. Prognoz. 1999;2:204-8.
  • Aird SD. Ophidian envenomation strategies and the role of purines. Toxicon. 2002;40:335–93.
  • Aird SD. Taxonomic distribution and quantitative analysis of free purine and pyrimidine nucleosides in snake venoms. Comp Biochem Physiol B Biochem Mol Biol. 2005;140:109–26.
  • Burnstock G. Purinergic signalling–an overview. Novartis Found Symp. 2006;276:26–4
  • Arıkan H, Göçmen B, Mermer A, Bahar H. An electrophoretic comparison of the venoms of a colubrid and various viperid snakes from Turkey and Cyprus, with some taxonomic and phylogenetic implications. Zootaxa. 2005;1038:1–10.
  • Myint-Lwin, Warrell DA, Phillips RE, Tin-Nu-Swe, Tun-Pe, Maung-Maung-Lay. Bites by Russell’s viper (Vipera russelli siamensis) in Burma: haemostatic, vascular, and renal disturbances and response to treatment. Lancet. 1985;2:1259-64.
  • Yüksel A, Ergin E, Barışık V. [Development of acute renal failure and disseminated intravascular coagulation after snakebite.] Fırat University Medical Journal of Sciences. 2009;23:37-9.
  • Chippaux JP. [Local complications of snake bites (author’s transl)]. Med Trop (Mars). 1982;42:177-83.
  • Milani JR, Jorge MT, de Campos FP, et al. Snake bites by the jararacuçu (Bothrops jararacussu): clinicopathological studies of 29 proven cases in São Paulo State, Brazil. QJM. 1997;90:323-34.
  • Büyük Y, Koçak U, Yazıcı YA, Gülpınar SS, Kır Z. Yılan ısırmalarına bağlı ölüm. Türkiye Klinikleri Adli Tıp Dergisi. 2007;4:127-30.
  • Altun DE, Altun DI, Ayaz B. Our Clinical Experiences in Snake Bites. J Turk Soc Intens Care. 2016;14:100-4.
  • Büyükbebeci O, Barlas SK, Karakurum G, Güleç A, Demir S. Our Clinical Experiences in Snake Bites. Journal of Arthroplasty Arthroscopic Surgery. 2001;12:47-9.
  • Benvenuti LA, Franca FO, Barbaro KC, Nunes JR, Cardoso JL. Pulmonary haemorrhage causing rapid death after Bothrops jararacussu snakebite: a case report. Toxicon. 2003;42:331-4.
  • Roberts JR, Otten EJ. Snakebites and other reptiles. In: Goldfrank LR, editor. Goldfrank’s toxicologic emergencies. Stamford (Conn): Appleton & Lange, 1998:1603-23.
  • Acıkalın A, Gökel Y, Kuvandık G, Duru M, Köseoğlu Z, Satar S. The efficacy of low-dose antivenom therapy on morbidity and mortality in snakebite cases. American Journal of Emergency Medicine. 2008;26:402–7.
  • Uzawa SJ. Phosphatases. Biochem. 1932;15:19.
  • Rael ED. Venom Phosphatases and 5`Nucleotidase. In: Bailey GS (ed.). Enzymes from Snake VenomsAlaken Press, Ft. Collins, 1998;405–22.
  • Sifford CA, Sifford DH, Johnson BD. Acid phosphatase and proteinase activities of selected crotalid venoms. SAAS Bull Biochem Biotechnol. 1996;9:9–16.
  • Iwanaga S, Suzuki T. Enzymes in snake venom. In: Hornburg H (ed.). Snake venoms, Handbook of Exp. Pharmacol. Springer-Verlag, Berlin, 1979;52:61–158.
  • Gutierrez JM, Rucavado A. Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage. Biochimie. 2000;82:841–50.
  • Zengin S, Yilmaz M, Al B, et.al. Plasma exchange as a complementary approach to snake bite treatment: An academic emergency department’s experiences. Transfusion and Apheresis Science. 2013;49:494–8.
  • Langley RL. Animal-related fatalities in the United States—an update. Wilderness Environ Med. 2005;16:67.
  • Gold BS, Wingert WA. Snake venom poisoning in the United States: a review of therapeutic practice. South Med J. 1994;87:579-89.
  • Davidson TM, Schafer SF. Rattlesnake bites. Guidelines for aggressive treatment. Postgrad Med. 1994;96:107-14.
  • Premawardhena AP, de Silva CE, Fonseka MM, Gunatilake SB, de Silva HJ. Low dose subcutaneous adrenaline to prevent acute adverse reactions to antivenom serum in people bitten by snakes: randomised, placebo controlled trial. BMJ. 1999;318:1041-3.
  • Reading CJ. Incidence, pathology, and treatment of adder (Vipera berus L.) bites in man. J Accid Emerg Med. 1996;13:346-51.
  • Roberts JR, Otten EJ. Snakebites and other reptiles. In: Goldfrank LR, editor. Goldfrank’s toxicologic emergencies. Stamford (Conn): Appleton & Lange; 1998:1603-23.
  • Scharman EJ, Noffsinger VD. Copperhead snakebites: clinical severity of local effects. Ann Emerg Med. 2001;38:55-61.

Citation

Akoz A, Yildiz V, Orun S, Turkdogan KA, Duman A. Management of Poisonous Snake Bites: Analysis of 29 Cases. J Clin Exp Invest. 2018;9(4):140-4. https://doi.org/10.5799/jcei/3998